These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 9066697)
1. High rate of p53 overexpression in head and neck carcinomas detected with a refined ELISA. Maass JD; Gottschlich S; Goeroegh T; Bruhn T; Lippert BM; Paulsen JI; Werner JA Anticancer Res; 1997; 17(1A):473-8. PubMed ID: 9066697 [TBL] [Abstract][Full Text] [Related]
2. Analysis of p53 antibody response in patients with squamous cell carcinoma of the head and neck. Lavieille JP; Lubin R; Soussi T; Reyt E; Brambilla C; Riva C Anticancer Res; 1996; 16(4C):2385-8. PubMed ID: 8816839 [TBL] [Abstract][Full Text] [Related]
3. Relationship between immunohistochemically detectable p53 protein and prognostic factors in head and neck tumors. Gapany M; Pavelic ZP; Gapany SR; Pavelic L; Li YG; Craven JM; Jones H; Biddinger P; Stambrook PJ; Gluckman JL Cancer Detect Prev; 1993; 17(3):379-86. PubMed ID: 8402724 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma. Homann N; Nees M; Conradt C; Dietz A; Weidauer H; Maier H; Bosch FX Clin Cancer Res; 2001 Feb; 7(2):290-6. PubMed ID: 11234882 [TBL] [Abstract][Full Text] [Related]
5. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma]. Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157 [TBL] [Abstract][Full Text] [Related]
6. A prospective study of p53 expression and its correlation with clinical response of radiotherapy in nasopharyngeal carcinoma. Ho KY; Kuo WR; Chai CY; Tsai SM; Sheu SH; Wu SC; Juan KH Laryngoscope; 2001 Jan; 111(1):131-6. PubMed ID: 11192881 [TBL] [Abstract][Full Text] [Related]
7. Improved immunohistochemical detection of p53 protein in paraffin--embedded tissues reveals elevated levels in most head and neck and lung carcinomas: correlation with clinicopathological parameters. Pavelic ZP; Gluckman JL; Gapany M; Reising J; Craven JM; Kelley DJ; Pavelic L; Gapany S; Biddinger P; Stambrook PJ Anticancer Res; 1992; 12(5):1389-94. PubMed ID: 1444195 [TBL] [Abstract][Full Text] [Related]
8. [Antibody formation to cellular p53 protein in patients with squamous cell carcinomas of the upper respiratory and digestive system]. Maass JD; Gottschlich S; Lippert BM; Niemann AM; Görögh T; Werner JA Laryngorhinootologie; 1996 Jan; 75(1):53-6. PubMed ID: 8851121 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer. Edström S; Cvetkovska E; Westin T; Young C Laryngoscope; 2001 Jan; 111(1):124-30. PubMed ID: 11192880 [TBL] [Abstract][Full Text] [Related]
10. p53 autoantibodies as tumor marker in head and neck squamous cell cancer. Gottschlich S; Hoffmann M; Maass JD; Görörgh T; Buhmann V; Hoffmann-Fazel A; Rudert H; Maune S Anticancer Res; 2003; 23(2A):913-5. PubMed ID: 12820322 [TBL] [Abstract][Full Text] [Related]
11. Head and neck cancer and p53-immunogenicity. Maass JD; Gottschlich S; Goeroegh T; Lippert BM; Werner JA Anticancer Res; 1997; 17(4B):2873-4. PubMed ID: 9329551 [TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients. Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of p53 protein overexpression versus gene sequencing in urinary bladder carcinomas. Bernardini S; Adessi GL; Billerey C; Chezy E; Carbillet JP; Bittard H J Urol; 1999 Oct; 162(4):1496-501. PubMed ID: 10492244 [TBL] [Abstract][Full Text] [Related]
14. A new prognostic indicator for head and neck cancer--p53 serum antibodies? Gottschlich S; Folz BJ; Goeroegh T; Lippert BM; Maass JD; Werner JA Anticancer Res; 1999; 19(4A):2703-5. PubMed ID: 10470224 [TBL] [Abstract][Full Text] [Related]
15. Analysis of tumor suppressor p53 status in head and neck squamous cell carcinoma. Smardova J; Ksicova K; Binkova H; Krpensky A; Pavlova S; Rottenberg J; Koukalova H Oncol Rep; 2004 Apr; 11(4):923-9. PubMed ID: 15010896 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of P53 histochemistry and DNA histogram parameters in head and neck malignancies. Tamás L; Kraxner H; Mechtler L; Répássy G; Ribári O; Hirschberg A; Szentkúti G; Járay B; Szentirmay Z Anticancer Res; 2000; 20(5C):4031-7. PubMed ID: 11268497 [TBL] [Abstract][Full Text] [Related]
17. [Detection of p53 protein in advanced head and neck cancer]. Lassaletta L; Brandáriz JA; Benito A; Gómez C; Ballestín C; Hitt R; De La Cruz J; Alvarez-Vicent JJ Acta Otorrinolaringol Esp; 1999; 50(8):613-8. PubMed ID: 10619896 [TBL] [Abstract][Full Text] [Related]
18. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck. Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502 [TBL] [Abstract][Full Text] [Related]
19. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227 [TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against P53 protein in patients with transitional cell carcinoma of the bladder. Sanchez-Carbayo M; Chulia MT; Niveiro M; Aranda I; Mira A; Soria F Anticancer Res; 1999; 19(4C):3531-7. PubMed ID: 10629648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]